Holen Sie sich die Stockscreener-App
22.59
1.44%
-0.33
Handel nachbörslich:
22.59
Schlusskurs vom Vortag:
$22.92
Offen:
$22.82
24-Stunden-Volumen:
757.84K
Relative Volume:
1.09
Marktkapitalisierung:
$2.76B
Einnahmen:
$1.72B
Nettoeinkommen (Verlust:
$12.82M
KGV:
225.90
EPS:
0.1
Netto-Cashflow:
$98.59M
1W Leistung:
-3.21%
1M Leistung:
-11.27%
6M Leistung:
+24.94%
1J Leistung:
+15.31%
1-Tages-Spanne:
$22.13
$22.91
1-Wochen-Bereich:
$22.13
$24.19
52-Wochen-Spanne:
$15.92
$26.04
Privia Health Group Inc Stock (PRVA) Company Profile
Firmenname
Privia Health Group Inc
Sektor
Branche
Telefon
571-366-8850
Adresse
950 N. GLEBE RD., SUITE 700, ARLINGTON
Vergleichen Sie PRVA mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
PRVA
Privia Health Group Inc
|
22.59 | 2.76B | 1.72B | 12.82M | 98.59M | 0.10 |
|
VEEV
Veeva Systems Inc
|
234.21 | 38.81B | 2.75B | 714.14M | 1.09B | 4.33 |
|
SOLV
Solventum Corp
|
74.75 | 12.84B | 8.26B | 66.00M | 1.17B | 0.3682 |
|
DOCS
Doximity Inc
|
58.51 | 11.36B | 516.85M | 174.11M | 217.38M | 0.87 |
|
TEM
Tempus Ai Inc
|
47.83 | 10.16B | 640.44M | -743.28M | -206.93M | -11.29 |
|
HQY
Healthequity Inc
|
86.96 | 7.54B | 1.15B | 96.70M | -161.99M | 1.09 |
Privia Health Group Inc Stock (PRVA) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2025-01-10 | Eingeleitet | Needham | Buy |
| 2024-12-16 | Eingeleitet | Macquarie | Outperform |
| 2024-10-11 | Eingeleitet | KeyBanc Capital Markets | Overweight |
| 2024-05-30 | Eingeleitet | Robert W. Baird | Outperform |
| 2024-04-22 | Eingeleitet | Citigroup | Buy |
| 2024-03-06 | Eingeleitet | Barclays | Equal Weight |
| 2024-02-26 | Fortgesetzt | Jefferies | Buy |
| 2024-02-22 | Herabstufung | BofA Securities | Buy → Neutral |
| 2023-12-06 | Eingeleitet | JMP Securities | Mkt Outperform |
| 2023-06-13 | Eingeleitet | Evercore ISI | Outperform |
| 2023-04-12 | Eingeleitet | Stephens | Overweight |
| 2023-03-10 | Eingeleitet | RBC Capital Mkts | Outperform |
| 2023-02-03 | Eingeleitet | Goldman | Buy |
| 2022-12-09 | Eingeleitet | Stifel | Buy |
| 2022-12-08 | Eingeleitet | UBS | Buy |
| 2022-09-07 | Fortgesetzt | Truist | Buy |
| 2022-05-03 | Eingeleitet | BofA Securities | Buy |
| 2022-04-28 | Eingeleitet | BTIG Research | Buy |
| 2022-04-01 | Fortgesetzt | Credit Suisse | Outperform |
| 2022-03-30 | Eingeleitet | Guggenheim | Buy |
| 2022-02-22 | Hochstufung | Cowen | Market Perform → Outperform |
| 2022-01-03 | Eingeleitet | Jefferies | Buy |
| 2021-09-27 | Eingeleitet | SVB Leerink | Outperform |
| 2021-09-10 | Eingeleitet | Cowen | Market Perform |
| 2021-05-24 | Eingeleitet | Canaccord Genuity | Buy |
| 2021-05-24 | Eingeleitet | Credit Suisse | Outperform |
| 2021-05-24 | Eingeleitet | JP Morgan | Overweight |
| 2021-05-24 | Eingeleitet | Piper Sandler | Overweight |
| 2021-05-24 | Eingeleitet | Truist | Buy |
| 2021-05-24 | Eingeleitet | William Blair | Outperform |
Alle ansehen
Privia Health Group Inc Aktie (PRVA) Neueste Nachrichten
Natixis Advisors LLC Acquires 2,360 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Avantax Advisory Services Inc. Reduces Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Swiss National Bank Purchases 1,700 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Proficio Capital Partners LLC Takes $464,000 Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Acquired by PNC Financial Services Group Inc. - Defense World
Privia Health Group, Inc. (NASDAQ:PRVA) Receives Average Rating of “Buy” from Brokerages - Defense World
Needham & Company LLC Reiterates “Buy” Rating for Privia Health Group (NASDAQ:PRVA) - Defense World
Breaking Down Privia Health Gr: 10 Analysts Share Their Views - Benzinga
Charles Schwab Investment Management Inc. Has $22.17 Million Stock Position in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Atria Investments Inc Has $274,000 Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
This Insider Has Just Sold Shares In Privia Health Group - Simply Wall St
Privia Health Group, Inc. (NASDAQ:PRVA) Shares Bought by Victory Capital Management Inc. - Defense World
Privia Health group CEO Parth Mehrotra sells $252,651 in stock - Investing.com
Privia Health group CEO Parth Mehrotra sells $252,651 in stock By Investing.com - Investing.com Australia
US Bancorp DE Buys 1,134 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health CFO David Mountcastle sells $141,658 in stock By Investing.com - Investing.com South Africa
Privia Health EVP Fargis Edward C sells shares worth $120,255 By Investing.com - Investing.com Canada
Top Executives at Privia Health Group Cash Out on Stock Sales - TipRanks
Privia Health EVP Fargis Edward C sells shares worth $120,255 - Investing.com India
Privia Health CFO David Mountcastle sells $141,658 in stock - Investing.com
Privia Health Group Executives Sell Shares to Cover Tax Obligations - TradingView
Privia Health Group Executives Sell Shares for Tax Obligations - TradingView
Proficio Capital Partners LLC Invests $464,000 in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
PRVA Shares Experience Decline in Value - Knox Daily
Privia Health adjusts executive pay structure By Investing.com - Investing.com South Africa
Privia Health adjusts executive pay structure - Investing.com India
Bank of New York Mellon Corp Sells 227,357 Shares of Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Jefferies raises Privia Health stock price target to $29 - Investing.com India
Privia Health, Corcept and three other low-key but high-earnings growth potential stocks to invest in 2025 - MSN
When Should You Buy Privia Health Group, Inc. (NASDAQ:PRVA)? - Yahoo Finance UK
Leerink Partnrs Has Pessimistic View of PRVA Q1 Earnings - Defense World
Privia Health Group (NASDAQ:PRVA) Price Target Raised to $30.00 - Defense World
Privia Health Group (NASDAQ:PRVA) Price Target Raised to $40.00 - Defense World
Canaccord lifts Privia Health stock target to $30, maintains Buy - Investing.com
Brokerages Set Privia Health Group, Inc. (NASDAQ:PRVA) PT at $25.19 - MarketBeat
Versor Investments LP Acquires New Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - MarketBeat
Privia Health Group (NASDAQ:PRVA) Releases Quarterly Earnings Results, Misses Estimates By $0.02 EPS - MarketBeat
Privia Health Group, Inc. (NASDAQ:PRVA) Q4 2024 Earnings Call Transcript - MSN
JMP raises Privia Health stock target to $29 on strong outlook - Investing.com Canada
Privia Health Group Reports Strong 2024 Financial Results - TipRanks
Privia Health Group (NASDAQ:PRVA) Reaches New 1-Year HighHere's What Happened - MarketBeat
Taking on analysts’ expectations and winning: Privia Health Group Inc (PRVA) - SETE News
Truist Adjusts Price Target on Privia Health Group to $30 From $27, Maintains Buy Rating - Marketscreener.com
UBS Adjusts Price Target on Privia Health Group to $31 From $27, Keeps Buy Rating - Marketscreener.com
JMP raises Privia Health stock target to $29 on strong outlook By Investing.com - Investing.com South Africa
Privia Health: Q4 Earnings Snapshot - The Herald Review
Rhumbline Advisers Grows Stock Holdings in Privia Health Group, Inc. (NASDAQ:PRVA) - Defense World
Privia Health Group’s Strong Performance and Promising Outlook Justifies Buy Rating - TipRanks
Finanzdaten der Privia Health Group Inc-Aktie (PRVA)
Umsatz
Nettogewinn
Free Cashflow
ENV
2.06%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):